Accessibility Menu
 

Biome Australia

(ASX) BIO

Current Price$0.34
Market Cap$76.38M
Since IPO (2021)+179%
5 YearN/A
1 Year-25%
1 Month-12%

Biome Australia Financials at a Glance

Market Cap

$76.38M

Revenue (TTM)

$37.81M

Net Income (TTM)

$1.25M

EPS (TTM)

$0.00

P/E Ratio

77.91

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$0.34

Volume

265,942

Open

$0.34

Previous Close

$0.34

Daily Range

$0.34 - $0.36

52-Week Range

$0.30 - $0.63

BIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biome Australia

Industry

Personal Products

CEO

Blair William Brabin Vega Norfolk

Headquarters

Cremorne, VIC 3121, AU

BIO Financials

Key Financial Metrics (TTM)

Gross Margin

61%

Operating Margin

3%

Net Income Margin

4%

Return on Equity

18%

Return on Capital

11%

Return on Assets

8%

Earnings Yield

1.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$76.38M

Shares Outstanding

228.00M

Volume

265.94K

Short Interest

0.00%

Avg. Volume

229.47K

Financials (TTM)

Gross Profit

$11.26M

Operating Income

$278.46K

EBITDA

$143.57K

Operating Cash Flow

$2.82M

Capital Expenditure

$37.14K

Free Cash Flow

$2.86M

Cash & ST Invst.

$2.75M

Total Debt

$3.07M

Biome Australia Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$12.40M

+106.1%

Gross Profit

$7.43M

+112.5%

Gross Margin

59.96%

N/A

Market Cap

$76.38M

N/A

Market Cap/Employee

$2.55M

N/A

Employees

30

N/A

Net Income

$1.18M

+177.1%

EBITDA

$823.76K

+150.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$924.82K

+61.4%

Accounts Receivable

$3.31M

+45.2%

Inventory

$3.89M

+87.0%

Long Term Debt

$694.89K

+131.9%

Short Term Debt

$1.74M

+50.8%

Return on Assets

7.78%

N/A

Return on Invested Capital

10.71%

N/A

Free Cash Flow

$2.04M

+406.5%

Operating Cash Flow

$2.09M

+418.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATX.AXAmplia Therapeutics Limited
$0.15+0.00%
CYP.AXCynata Therapeutics Limited
$0.29+1.72%
ILA.AXIsland Pharmaceuticals Limited
$0.37+1.37%
ATH.AXAlterity Therapeutics Limited
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$67.86-0.02%
NOKNokia
$9.55+0.01%

Questions About BIO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.